Cognizant Technology Solutions Corporation (CTSH) Stock Forecast
Data as of Sep 16, 2026Technology · Current price $63.63 (-0.71%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 9, 2026 | Dan Dolev | Mizuho Securities | $87.00 | +36.7% |
| Jan 28, 2026 | Jonathan Lee | Guggenheim | $100.00 | +57.2% |
| Jan 23, 2026 | James Friedman | Susquehanna | $98.00 | +54.0% |
| Jan 22, 2026 | Meha Pau | Berenberg Bank | $107.00 | +68.2% |
| Oct 30, 2025 | Dan Dolev | Mizuho Securities | $85.00 | +33.6% |
| Oct 29, 2025 | James Schneider | Goldman Sachs | $84.00 | +32.0% |
| Oct 21, 2025 | Jason Kupferberg | Wells Fargo | $82.00 | +28.9% |
| Oct 21, 2025 | Jonathan Lee | Guggenheim | $85.00 | +33.6% |
| Dec 17, 2024 | Ramsey El-Assal | Barclays | $95.00 | +49.3% |
| Oct 29, 2024 | Dan Dolev | Mizuho Securities | $83.00 | +30.4% |
| Oct 22, 2024 | Bryan Keane | Deutsche Bank | $80.00 | +25.7% |
| Sep 11, 2024 | James Schneider | Goldman Sachs | $76.00 | +19.4% |
| Aug 28, 2024 | Daniel Perlin | RBC Capital | $82.00 | +28.9% |
| Aug 7, 2024 | Jason Kupferberg | Bank of America Securities | $75.00 | +17.9% |
| Aug 1, 2024 | Keith Bachman | BMO Capital | $85.00 | +33.6% |
| Jun 24, 2024 | James Schneider | Goldman Sachs | $72.00 | +13.2% |
| Jun 10, 2024 | Bryan Keane | Deutsche Bank | $70.00 | +10.0% |
| Apr 30, 2024 | Keith Bachman | BMO Capital | $77.00 | +21.0% |
| Apr 12, 2024 | James Faucette | Morgan Stanley | $65.00 | +2.2% |
| Jan 11, 2024 | Surinder Thind | Jefferies | $85.00 | +33.6% |
Top Analysts Covering CTSH
CTSH vs Sector & Market
| Metric | CTSH | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.63 | 2.37 | 2.42 |
| Analyst Count | 30 | 14 | 18 |
| Target Upside | +8.4% | +1939.9% | +19.5% |
| P/E Ratio | 13.83 | 38.34 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $22.27B | $22.38B | $22.46B | 21 |
| 2027-03-31 | $5.65B | $5.70B | $5.74B | 6 |
| 2027-06-30 | $5.78B | $5.83B | $5.88B | 6 |
| 2027-09-30 | $5.96B | $6.01B | $6.05B | 6 |
| 2027-12-31 | $5.91B | $5.97B | $6.01B | 6 |
| 2028-03-31 | $5.97B | $6.03B | $6.07B | 5 |
| 2028-06-30 | $6.14B | $6.19B | $6.24B | 5 |
| 2028-09-30 | $6.26B | $6.32B | $6.37B | 6 |
| 2028-12-31 | $6.23B | $6.28B | $6.33B | 8 |
| 2029-12-31 | $24.39B | $24.74B | $25.03B | 9 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $5.61 | $5.65 | $5.68 | 18 |
| 2027-03-31 | $1.44 | $1.46 | $1.47 | 10 |
| 2027-06-30 | $1.50 | $1.52 | $1.54 | 6 |
| 2027-09-30 | $1.58 | $1.60 | $1.61 | 7 |
| 2027-12-31 | $1.56 | $1.58 | $1.60 | 6 |
| 2028-03-31 | $1.56 | $1.58 | $1.59 | 7 |
| 2028-06-30 | $1.63 | $1.65 | $1.67 | 7 |
| 2028-09-30 | $1.68 | $1.70 | $1.72 | 12 |
| 2028-12-31 | $1.71 | $1.73 | $1.74 | 7 |
| 2029-12-31 | $6.14 | $6.26 | $6.35 | 4 |
Frequently Asked Questions
What is the analyst consensus for CTSH?
The consensus among 30 analysts covering Cognizant Technology Solutions Corporation (CTSH) is Hold with an average price target of $76.46.
What is the highest price target for CTSH?
The highest price target for CTSH is $107.00, set by Meha Pau at Berenberg Bank on 2026-01-22.
What is the lowest price target for CTSH?
The lowest price target for CTSH is $45.00, set by Ramsey El-Assal at Barclays on 2022-11-06.
How many analysts cover CTSH?
30 analysts have issued ratings for Cognizant Technology Solutions Corporation in the past 12 months.
Is CTSH a buy or sell right now?
Based on 30 analyst ratings, CTSH has a consensus rating of Hold (2.63/5) with a +8.4% upside to the consensus target of $76.46.
What are the earnings estimates for CTSH?
Analysts estimate CTSH will report EPS of $5.65 for the period ending 2026-12-31, with revenue estimated at $22.38B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.